A Wieck1, P M Haddad. 1. Manchester Mental Health and Social Care Trust, Manchester, UK. angelika.wieck@man.ac.uk
Abstract
BACKGROUND: Hyperprolactinaemia has for decades been an inevitable and neglected side-effect of antipsychotic medication. The recent introduction of prolactin-sparing antipsychotic agents makes a re-examination of this problem timely. AIMS: To review the literature on antipsychotic-induced hyperprolactinaemia and its consequences. METHOD: A search was made of the Medline database (1966-2002) for key articles, supplemented by cross-referencing. RESULTS: During antipsychotic treatment prolactin concentrations can rise to ten times normal levels or above, and existing data indicate that 17-78% of female patients have amenorrhoea with or without galactorrhoea. Survey data, however, suggest that clinicians underestimate the prevalence of these conditions. Long-term consequences of antipsychotic-related hypo-oestrogenism require further research but are likely to include premature bone loss. CONCLUSIONS: Antipsychotic-induced hyperprolactinaemia should become a focus of interest in the drug treatment of psychiatric patients.
BACKGROUND:Hyperprolactinaemia has for decades been an inevitable and neglected side-effect of antipsychotic medication. The recent introduction of prolactin-sparing antipsychotic agents makes a re-examination of this problem timely. AIMS: To review the literature on antipsychotic-induced hyperprolactinaemia and its consequences. METHOD: A search was made of the Medline database (1966-2002) for key articles, supplemented by cross-referencing. RESULTS: During antipsychotic treatment prolactin concentrations can rise to ten times normal levels or above, and existing data indicate that 17-78% of female patients have amenorrhoea with or without galactorrhoea. Survey data, however, suggest that clinicians underestimate the prevalence of these conditions. Long-term consequences of antipsychotic-related hypo-oestrogenism require further research but are likely to include premature bone loss. CONCLUSIONS: Antipsychotic-induced hyperprolactinaemia should become a focus of interest in the drug treatment of psychiatricpatients.
Authors: Stefan Cohrs; Cornelia Röher; Wolfgang Jordan; Andreas Meier; Gerald Huether; Wolfgang Wuttke; Eckart Rüther; Andrea Rodenbeck Journal: Psychopharmacology (Berl) Date: 2006-01-24 Impact factor: 4.530
Authors: Juan A Gallego; Jimmi Nielsen; Marc De Hert; John M Kane; Christoph U Correll Journal: Expert Opin Drug Saf Date: 2012-05-08 Impact factor: 4.250
Authors: Katherine W Reeves; Olivia I Okereke; Jing Qian; Shelley S Tworoger; Megan S Rice; Susan E Hankinson Journal: Cancer Causes Control Date: 2016-05-10 Impact factor: 2.506
Authors: Susan B Brown; Susan E Hankinson; Kathleen F Arcaro; Jing Qian; Katherine W Reeves Journal: Cancer Epidemiol Biomarkers Prev Date: 2015-11-17 Impact factor: 4.254